“The apprehension with utilizing non IID listed ingredients is justified as it is actually unattainable to evaluate if FDA would find the ‘novel excipient’ Secure for use inside of a drug products as there is not any defined course of action for analysis and approval of excipients. The FDA https://edwardz813auj7.wikicorrespondent.com/user